| Bioshares

Categories

July 14th, 2026

Imugene to Raise $11 Million in Placement and Looks for Licensing Deal

July 14th, 2026

Cogstate - Record Sales for FY2026

July 14th, 2026

Syntara's Compound Records Some Activity in Prodromal Parkinson's Disease

July 14th, 2026

Neuren - CHMP Reverses View on DAYBU in Europe

June 22nd, 2026

Steady Adoption by Big Pharma Continues for Clever Culture Systems

June 22nd, 2026

Double Negative for Cynata Therapeutics

June 22nd, 2026

Dimerix Secures Fifth International Licensing Deal

June 5th, 2026

Acrux Licenses HRT Product in Australia and Seeks to Bring First Women's Testosterone Therapy to Market in US

June 5th, 2026

Two Major Trial Readouts for Cynata Therapeutics this Month

June 5th, 2026

Aroa Biosurgery - "Breakout Year"

May 5th, 2026

Dimerix Clears Second Interim Review; Focus on Traditional Approval Route for DMX200

May 5th, 2026

Syntara: First of Five Milestones Approaching

May 5th, 2026

Clever Culture Systems - Continues Inroads into Top 20 Pharma

May 5th, 2026

Neuren Pharmaceuticals Update - Dividends on the Way?

April 20th, 2026

Another Strong Sales Quarter for Cogstate

April 20th, 2026

Blinklab Raises $17.5 Million

CUV1

March 26th, 2026

Clinuvel CEO to Continue with Key Strategy Role

BB12

March 26th, 2026

Blinklab Technology Selected by Moroccan Government for National Autism Screening Program

IMU2

March 12th, 2026

Imugene Announces $20 million Capital Raise

DXB

March 12th, 2026

Dimerix Completes Enrolment in Global Phase III Study & First Treatment of Last Patient

Pages

1
2
3
4
5
6
7
8
9
10
11